Holds one active US DMF and one valid CEP for carbidopa, filing since 2004. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 2 markets.
Holds one active US DMF and one valid CEP for carbidopa, filing since 2004. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 2 markets.
Holds one active US DMF and one valid CEP for carbidopa, filing since 2020. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds 2 active US DMFs for carbidopa, filing since 2022. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 6 markets.
Holds one active US DMF for carbidopa, filing since 2025. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 4 markets.
Holds 2 active US DMFs for carbidopa, filing since 2011. Its 2024 FDA inspection closed as VAI.
This page filters the worldwide Carbidopa manufacturer list to companies based in India. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Ask Fred which manufacturers are on record for carbidopa and what filings they hold.
Chat with Fred, your AI analyst